Hemo bioscience Teams Up With Ortho Clinical Diagnostics to Deliver New Products

Durham, N.C. (September 3, 2013) – Hemo bioscience (HBS) is pleased to announce a new partnership with Ortho Clinical Diagnostics (OCD), a leader in the Immunohematology industry. HBS, a growing developer and manufacturer of innovative reagents, and OCD, a well-established brand with a long history of providing the Blood Bank Community with quality products and services, have developed an exclusive distribution arrangement. We anticipate that this agreement will provide you with additional products, superior service and enhanced delivery options.

ELUclear is the industry’s most intuitive and convenient glycine acid elution kit for the recovery of red cell bound antibodies. It is validated for use in both tube and MTS gel techniques. The kit includes color coded vials of acid and buffer solution, concentrated wash solution, and a wash bottle for simple wash solution preparation.

HBS C3 Control Cells received FDA 510(k) clearance in 2012. They are complement coated with C3 to confirm the efficacy of the AHG reagent used during Direct and Indirect Anti-Globulin Tests.

HBS ELUclear and C3 Control Cells will be exclusively available through OCD beginning October 2013. To place your order please call OCD Customer Service at (800) 828-6316. Note: HBS C3 Control Cells are a reagent red cell and require a 12 month standing order. Please allow 60 days to setup and begin your standing order. They are manufactured on a 28-day cycle and will be companion shipped with OCD 0.8% reagent red cells. Please visit hemobisocience.com for a shipping schedule.


Founded in 2003, Hemo bioscience Inc. manufactures and distributes blood typing reagents and ancillary products used by hospitals, reference laboratories and donor centers in the area of compatibility testing.